Chronic Kidney disease. Chronic kidney disease (CKD)
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Chronic Kidney disease (CKD) patients( moderate to severe) Having informed consent to enter the study
Exclusion criteria
Exclusion criteria: Uncontrolled Diabetes Mellitus (Hb A1C>7 & Fsting Blood Sugar>130 mg/dl) Uncontrolled hypertension ( systolic Blood pressure>160 & diastolic Blood Pressure >100 mmHg) Malignancies Obstructive Uropathy Stage 5 Chronic Kidney disease (CKD) active infection intake of Nephrotoxic drugs severe Congestive Heart Failure (Ejection Fraction<40%) Liver failure (cirrhosis) Poly cystic Kidney disease Pregnancy Renal transplantation Dissatisfaction with continued cooperation Smoking and drugs abuse Breastfeeding Accompanied by acute kidney diseases
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| ?Serum Creatinine. Timepoint: 0-45-90 days. Method of measurement: Laboratory.;Serum Lipid. Timepoint: 0-45-90 days. Method of measurement: Laboratory.;Urine Protein. Timepoint: 0-45-90 days. Method of measurement: Laboratory.;Hematuria. Timepoint: 0-45-90 days. Method of measurement: Laboratory. | — |
Secondary
| Measure | Time frame |
|---|---|
| Serum Uric Acid. Timepoint: 0-45-90 days. Method of measurement: Laboratory.;C-Reactive Protein (CRP). Timepoint: 0-45-90 days. Method of measurement: Laboratory.;Liver Function test. Timepoint: 0-45-90 days. Method of measurement: Laboratory. | — |
Countries
Iran (Islamic Republic of)
Contacts
Mashhad University of Medical Sciences